Author | Kevin Kunzmann

Articles

COVID-19 Vaccine Candidate Induces Immune Response in All Phase 1 Participants

July 15, 2020

New findings show the vaccine candidate mRNA-1273, encoded with a stabilized prefusion SARS-CoV-2 spike protein, induced anti-SARS-CoV-2 immune responses in all of the trial’s participants, without any trial-limiting safety concerns identified.